Related Experiment Video
Updated: Jun 20, 2026

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation
Published on: July 10, 2012
Therapeutic failure in a renal transplant patient with Pneumocystis jiroveci pneumonia: a case report
Nikolaos K Archontoulis1, Chryssoula V Staikou
1Intensive Care Unit, Laiko General Hospital, Aretaieio Hospital, 11528 Athens, Greece.
Objectives:
Pneumocystis jiroveci pneumonia is common in immunocompromised individuals.
Patients:
This case report describes an immunosuppressed patient who acquired P jiroveci pneumonia 6 months after renal transplant surgery.
Results:
The patient experienced many pneumonia-related complications and adverse effects from drug therapy, and despite treatment with various antibiotic agents, he died on the 62nd day after his admission to the intensive care unit.
Conclusions:
The therapeutic failure of the drug of choice (co-trimoxazole) was evident. This case raises questions about the development of P jiroveci resistance to current therapies.
Insights
Pneumocystis jiroveci pneumonia is a serious risk for immunocompromised patients. A renal transplant recipient experienced fatal complications despite treatment, highlighting potential drug resistance.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Transplantation Medicine
Background:
- Pneumocystis jiroveci pneumonia (PJP) is a significant opportunistic infection in immunocompromised individuals.
- Renal transplant recipients are at high risk due to long-term immunosuppression.
Observation:
- This case report details a patient who developed PJP six months post-renal transplant.
- The patient suffered severe pneumonia-related complications and adverse drug reactions.
Findings:
- Treatment failure occurred despite the use of multiple antibiotic agents, including the recommended co-trimoxazole.
- The patient ultimately died due to complications of PJP.
Implications:
- This case underscores the challenges in treating PJP in transplant patients.
- It raises critical concerns regarding the potential emergence of P jiroveci resistance to established therapies.
Related Concept Videos
Kidney Transplant III: Nursing Management
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Pneumonia III: Complications and Assessment
Acute Pyelonephritis II: Diagnostic Studies and Management
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

